ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 145 filers reported holding ITEOS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,317,348 | -16.4% | 1,581,493 | +1.0% | 0.00% | 0.0% |
| Q2 2023 | $20,723,274 | -16.7% | 1,565,202 | -14.3% | 0.00% | 0.0% |
| Q1 2023 | $24,870,792 | -63.3% | 1,827,391 | -47.4% | 0.00% | -50.0% |
| Q4 2022 | $67,858,548 | +69.0% | 3,474,580 | +64.8% | 0.00% | -33.3% |
| Q3 2022 | $40,155,000 | -21.3% | 2,107,868 | -14.9% | 0.00% | 0.0% |
| Q2 2022 | $51,054,000 | -7.3% | 2,478,332 | +44.8% | 0.00% | 0.0% |
| Q1 2022 | $55,089,000 | +55.0% | 1,711,891 | +124.3% | 0.00% | +50.0% |
| Q4 2021 | $35,542,000 | +308.7% | 763,351 | +137.0% | 0.00% | – |
| Q3 2021 | $8,697,000 | +6.6% | 322,107 | +1.2% | 0.00% | – |
| Q2 2021 | $8,161,000 | -66.0% | 318,169 | -54.7% | 0.00% | -100.0% |
| Q1 2021 | $24,029,000 | +275.9% | 703,010 | +272.0% | 0.00% | – |
| Q4 2020 | $6,392,000 | +97.5% | 189,002 | +44.0% | 0.00% | – |
| Q3 2020 | $3,237,000 | – | 131,229 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $52,174,000 | 19.87% |
| MPM BioImpact LLC | 1,745,943 | $33,260,000 | 7.88% |
| Boxer Capital, LLC | 2,154,058 | $41,035,000 | 2.31% |
| TANG CAPITAL MANAGEMENT LLC | 937,500 | $17,859,000 | 2.19% |
| RA Capital Management | 4,417,259 | $84,149,000 | 1.80% |
| BVF INC/IL | 1,810,835 | $34,496,000 | 1.42% |
| Zebra Capital Management LLC | 12,271 | $234,000 | 0.89% |
| Integral Health Asset Management, LLC | 195,000 | $3,715,000 | 0.72% |
| Prairiewood Capital, LLC | 32,269 | $615,000 | 0.51% |
| DAFNA Capital Management LLC | 97,560 | $1,859,000 | 0.50% |